Insider Transactions Reported by 18 Insiders of Design Therapeutics, Inc.

Symbol
DSGN on Nasdaq
Location
Carlsbad, CA

Insiders trading volume in the past year

Design Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Arsani William Director $19,188,750 -$2,953,792 -13% 13 Aug 2025
SR One Capital Fund I Aggregator LP 10%+ Owner $15,317,639 16 Dec 2022
Deepa Prasad Director $125,400 10 Jun 2025
Dawn Giangiulio Principal Accounting Officer $17,603 13 Aug 2021
Jae B. Kim Chief Medical Officer $11,162 13 Mar 2024
Heather A. Berger Director 10 Jun 2025
Sean Jeffries Chief Operating Officer 02 Jan 2026
Julie Burgess Chief Accounting Officer 02 Jan 2026
Aseem Z. Ansari 10%+ Owner 01 Dec 2023
Joao Siffert MD President and CEO, Director 01 Feb 2023
Pratik Shah President, CEO and Chairperson, Director 02 Jan 2026
Simeon George Director, 10%+ Owner 10 Jun 2025
DUNHAM TRUST Co 10%+ Owner 01 Oct 2024
Justin D. Gover Director 02 Jan 2026
RODNEY W. LAPPE Director 10 Jun 2025
John P. Schmid Director 10 Jun 2025
Chris Storgard Chief Medical Officer 02 Jan 2026
Stella Xu Director 31 May 2023

Recent Insider Transactions by Companies or Individuals for Design Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.